
Former unicorn genetics startup Human Longevity loses its horn
The company's valuation has declined 80 percent, from a $1.6 billion peak to $310 million, according to The Wall Street Journal.
The company's valuation has declined 80 percent, from a $1.6 billion peak to $310 million, according to The Wall Street Journal.
Genomic sequencing legend Craig Venter now stands accused of stealing trade secrets and attempting to poach employees by the very company he founded.
Mayo Clinic has developed a new tool that could speed up the time it takes for digital health companies to validate their tech to hospitals.
In a new analysis, Accenture dives deeper into digital health funding. The assessment includes a prediction that annual investment in digital health startups will reach $7 billion by the end of 2017.
With every partnership signed, Google's mysterious biotech spin-out Calico reveals a little bit more about its plans to extend human lifespans.
J. Craig Venter will step down as CEO of his ambitious genomics-driven biotech Human Longevity, effective January 9.